Ssur Hf Company Insiders
| OSSUY Stock | USD 4.00 0.00 0.00% |
Ssur Hf employs about 3.9 K people. The company is managed by 10 executives with a total tenure of roughly 9082 years, averaging almost 908.0 years of service per executive, having 389.2 employees per reported executive. Break down of Ssur Hf's management performance can provide insight into the company performance.
| Christian Robinson Insider Ex Americas |
| Margret Fridriksdottir Insider Exec Strategy |
Ssur |
Ssur Hf Management Team Effectiveness
The company has return on total asset (ROA) of 0.0326 % which means that it generated a profit of $0.0326 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0685 %, meaning that it generated $0.0685 on every $100 dollars invested by stockholders. Ssur Hf's management efficiency ratios could be used to measure how well Ssur Hf manages its routine affairs as well as how well it operates its assets and liabilities.Ssur Hf Workforce Comparison
ssur hf is regarded fifth in number of employees category among its peers. The total workforce of Medical Devices industry is now estimated at about 135,523. Ssur Hf holds roughly 3,892 in number of employees claiming about 2.87% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. ssur hf Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ssur hf Price Series Summation is a cross summation of Ssur Hf price series and its benchmark/peer.
Ssur Hf Notable Stakeholders
A Ssur Hf stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ssur Hf often face trade-offs trying to please all of them. Ssur Hf's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ssur Hf's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Christian Robinson | Ex Americas | Profile | |
| Margret Fridriksdottir | Exec Strategy | Profile | |
| Sigurborg Arnarsdottir | Compliance Officer | Profile | |
| Olafur Gylfason | Ex Markets | Profile | |
| Edda Luovigsdottir | Investor Director | Profile | |
| Sveinn Solvason | Pres CEO | Profile | |
| Ossur Kristinsson | Founder | Profile | |
| Gudny Sveinsdottir | Chief Officer | Profile | |
| Egill Jonsson | Ex Operations | Profile | |
| Gudjon Karason | Ex Clinics | Profile |
About Ssur Hf Management Performance
The success or failure of an entity such as ssur hf often depends on how effective the management is. Ssur Hf management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ssur management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ssur management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ssur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. ssur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Ossur HF is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Ssur Hf's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ssur hf. Check Ssur Hf's Beneish M Score to see the likelihood of Ssur Hf's management manipulating its earnings.
Ssur Hf Workforce Analysis
Traditionally, organizations such as Ssur Hf use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ssur Hf within its industry.Ssur Hf Manpower Efficiency
Return on Ssur Hf Manpower
| Revenue Per Employee | 184.6K | |
| Revenue Per Executive | 71.9M | |
| Net Income Per Employee | 10.9K | |
| Net Income Per Executive | 4.3M |
Additional Tools for Ssur Pink Sheet Analysis
When running Ssur Hf's price analysis, check to measure Ssur Hf's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ssur Hf is operating at the current time. Most of Ssur Hf's value examination focuses on studying past and present price action to predict the probability of Ssur Hf's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ssur Hf's price. Additionally, you may evaluate how the addition of Ssur Hf to your portfolios can decrease your overall portfolio volatility.